Osing, Reyme .
HRN: 22-34-08 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/14/2022
CEFUROXIME 500MG (TAB)
12/14/2022
12/21/2022
ORAL
1 CP
Bid
S/p D An C
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes